@article{article, title  = {{Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the ‘MOI-A’ study; a randomised, phase 2/pilot, dose-escalating trial}},

 publisher = {{BMJ}},

 url = {{https://doi.org/10.1136/bmjopen-2025-107243 }},

 year = {{2025}},

 month = {{12}},

 author = {{Haji Sadeghi M and Cohen J and Williams B and Wilkinson A and Sumpter S and Simms L and Huang C and Pugh K and Heath C and Sangiorgi L and Gurioli F et al}},

 doi = {{10.1136/bmjopen-2025-107243}},

 volume = {{15}},

 journal = {{BMJ Open}},

 issue = {{12}},

 pages = {{e107243-e107243}},

 note = {{Accessed on 2026/02/05}}}